Dr. Ranee Chatterjee, MD

Claim this profile

Duke University Hospital

Studies Kidney Disease
Studies Diabetes
1 reported clinical trial
3 drugs studied

Affiliated Hospitals

Image of trial facility.
Duke University Hospital

Clinical Trials Ranee Chatterjee, MD is currently running

Image of trial facility.

Combo Diabetes Drug

for Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonists (GLP-1RA). Participants will be followed for the occurrence of the trial primary endpoint of the total (first and recurrent) number of episodes of myocardial infarction (MI), stroke, arterial revascularization, hospitalization for heart failure, development of end-stage kidney disease, kidney transplantation, and mortality, counting all events from randomization until end of study.
Recruiting3 awards Phase 48 criteria

More about Ranee Chatterjee, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Ranee Chatterjee, MD has experience with
  • Combination Drug
  • GLP-1 Receptor Agonist
  • SGLT2 Inhibitor
Breakdown of trials Ranee Chatterjee, MD has run
Kidney Disease
Diabetes
Diabetic Nephropathy
Cardiovascular Disease

Other Doctors you might be interested in

Daniel Friedman, MDNYU Langone Health
Michael James, MDDuke University Hospital
Caroline Ozment, MDDuke University Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ranee Chatterjee, MD specialize in?
Ranee Chatterjee, MD focuses on Kidney Disease and Diabetes. In particular, much of their work with Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is Ranee Chatterjee, MD currently recruiting for clinical trials?
Yes, Ranee Chatterjee, MD is currently recruiting for 1 clinical trial in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Ranee Chatterjee, MD has studied deeply?
Yes, Ranee Chatterjee, MD has studied treatments such as Combination drug, GLP-1 receptor agonist, SGLT2 inhibitor.
What is the best way to schedule an appointment with Ranee Chatterjee, MD?
Apply for one of the trials that Ranee Chatterjee, MD is conducting.
What is the office address of Ranee Chatterjee, MD?
The office of Ranee Chatterjee, MD is located at: Duke University Hospital, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top